Tessuto adiposo epicardico: dagli aspetti biomolecolari alla pratica clinica
摘要
Epicardial adipose tissue (EAT) is a cardiovascular risk factor that plays a role in the progression of atrial fibrillation, coronary artery disease, and heart failure. Given its rapid metabolism, clinical measurability, and modifiability, EAT represents a therapeutic target for innovative drugs, such as glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter 2 inhibitors, which exert a positive cardiometabolic activity well beyond their effects on glucose and body weight (Supplementary Material).